Patient Guide to Lunsumio
Important Safety Information (cont'd). Your healthcare provider may temporarily stop or permanently stop treatment with LUNSUMIO if you develop severe side ...
1 MEDICATION GUIDE LUNSUMIO™ (lun-SUM-mee ... - Genentech
MEDICATION GUIDE. LUNSUMIO™ (lun-SUM-mee-oh). (mosunetuzumab-axgb) injection, for intravenous infusion. What is the most important information I should know ...
Starting treatment with LUNSUMIO™ (mosunetuzumab-axgb)
LUNSUMIO (mosunetuzumab-axgb) is a prescription medicine used to treat adults with follicular lymphoma whose cancer has come back or did not respond to ...
Printable LUNSUMIO™ (mosunetuzumab-axgb) Resources | HCP
A resource for patients to learn about what to expect with LUNSUMIO. Download the Information Sheet · Descargar la hoja de información en Español.
Patient Guide to Lunsumio (Mosunetuzumab-axgb) for Follicular ...
A Lunsumio treatment cycle is 21 days long. Patients should undergo eight cycles (about six months total) unless they experience unacceptable ...
Downloadable Resources | LUNSUMIO™ (mosunetuzumab-axgb)
Patient Brochure · Patient Wallet Card · Patient Consent Form · Infusion Information Sheet · Prescribing Information · Prefer it in print? · You may also be ...
Dosing, Administration, & Pharmacy Brochure - LUNSUMIO-hcp.com
See 17 for PATIENT COUNSELING INFORMATION and Medication. Guide. Revised: 12/2022. FULL PRESCRIBING INFORMATION: CONTENTS*. WARNING: CYTOKINE RELEASE SYNDROME.
Lunsumio™ (mosunetuzumab-axgb) - Information for Patients
What is LUNSUMIO? LUNSUMIO (mosunetuzumab-axgb) is a prescription medicine used to treat adults with follicular lymphoma whose cancer has come back or did not ...
Important Safety Information for Patients receiving Lunsumio ...
Please refer to the Patient Information. Leaflet (PIL) for Lunsumio (mosunetuzumab) for more information, which is available at: www.medicines.org.uk if based ...
Lunsumio, INN-mosunetuzumab - European Medicines Agency
The patient card describes the. Page 10. 10 common signs and symptoms of CRS and ICANS, including instructions on when a patient should seek medical attention.
How LUNSUMIO™ (mosunetuzumab-axgb) is given
Your treatment may begin in a clinic, local infusion center, or hospital. Some patients may be required to go to the hospital to manage certain side effects.
Lunsumio™ (mosunetuzumab-axgb) - Genentech Medical Information
Phase 2 Trial of LUNSUMIO (mosunetuzumab-axgb) for Patients with Relapsed/Refractory Follicular Lymphoma (R/R FL) after ≥2 prior lines of therapy.
Lunsumio Injection: Package Insert / Prescribing Information
LUNSUMIO is a bispecific CD20-directed CD3 T-cell engager indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma.
Lunsumio | European Medicines Agency (EMA)
What measures are being taken to ensure the safe and effective use of Lunsumio? The company that markets Lunsumio must provide patient cards with information ...
LUNSUMIO™ (mosunetuzumab-axgb) is a prescription medicine for ...
LUNSUMIO (mosunetuzumab-axgb) is a prescription medicine used to treat adults with follicular lymphoma whose cancer has come back or did not respond to ...
Questions to ask your doctor - lunsumio
When evaluating treatment options, and before starting LUNSUMIO™, ask your healthcare provider any questions you may have. It's a good idea to write down a ...
FDA approval of Lunsumio (mosunetuzumab-axgb) for adult patients ...
Welcome back to the D.I.S.C.O., FDA's Drug Information Soundcast in Clinical Oncology, Burst Edition, brought to you by FDA's Division of ...
Treatment of adult patients with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy.
How will I receive LUNSUMIO? - DailyMed
After Cycle 1 and Cycle 2, your healthcare provider will decide if you need to continue to take other medicines to help reduce side effects from LUNSUMIO during ...
Sign Up For Our Patient Support Program - lunsumio
Remember that you're not alone on your treatment journey. Join LUNSUMIO On Your Side today and receive a Welcome Kit that includes helpful information and ...